MHRA: No Summer Shortcut for Safe Weight Loss

Healthy weight loss takes time, not shortcuts. As demand for weight-loss medicines continues to rise, the MHRA is reminding people how to use GLP-1 medicines safely, spot illegal sellers and avoid diet changes that could interfere with their medicines

With prescription weight loss medicines being advertised illegally on social media alongside quick-fix slimming claims, the Medicines and Healthcare products Regulatory Agency (MHRA), warns Brits to not let summer slimming put their health at risk. 

From over-dosing on prescription weight-loss meds to buying dangerous fakes online, the MHRA reveals the mistakes that could leave you seriously ill, and the simple steps to lose weight safely. 

1. Follow doctor’s orders if you are prescribed a GLP-1 

If you’ve been prescribed a GLP-1 weight-loss medicine, don’t be tempted to fast-track your weight loss by upping your dose. Semaglutide (Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) should only be taken as prescribed by a healthcare professional.  

Follow doctors’ orders and take your prescribed GLP-1 alongside a healthy diet and a fitness regime. Whether you’re taking it for diabetes management or weight loss, maintaining good nutrition and exercise can help support muscle, bone, and overall health as your calorie intake changes. 

2. Steer Clear of Fake Weight-Loss Meds 

If you’re not eligible for a prescription for weight-loss medicines, don’t be tempted to buy them from unregulated websites or social media sellers. GLP-1 medicines authorised in the UK have only been shown to be safe and effective for people with a Body Mass Index (BMI) of 27 or more. Buying from rogue sellers is a huge risk. You can’t be sure what’s in the product, and some fake medicines are contaminated with toxic substances. 

Don’t be tempted by the online hype around retatrutide. It has not been authorised for use in the UK, meaning anyone selling this product is doing so illegally. These products haven’t been tested for safety, quality or effectiveness and there’s no guarantee that they even contain retatrutide. You could be putting your health at serious risk. 

Head of the MHRA’s Criminal Enforcement Unit, Andy Morling, said: “Rogue sellers are driven by profit, not your safety, and the fake medicines they sell could put your health at serious risk.

“These products may not contain the GLP-1 medicine you think you’re buying and could be contaminated with bacteria and other harmful substances.  

“Be wary of deals that seem too good to be true and check the pharmacy is registered with the General Pharmaceutical Council. The simple rule for staying safe is that if you’re offered a GLP-1 medicines without the need for a prescription – walk away.” 

3. Check Your Meds Before Changing Your Diet 

Trying to eat more healthily before your holiday? Great – but make sure your diet doesn’t clash with your medication. Always read the patient information leaflet before making dietary changes, as some foods could compromise medicines’ effectiveness. People taking simvastatin to lower their cholesterol should avoid grapefruit and grapefruit juice as they slow the rate the body breaks down the medicine, increasing the risk of serious side effects. 

Thinking about intermittent fasting? Remember that some medicines need to be taken with food to work most effectively and lower your risk of side effects. Metformin, used to treat diabetes, and the painkiller naproxen should both be taken with or after food to help prevent stomach upset.  

MHRA’s Chief Safety Officer, Alison Cave said: “There’s no shortcut to safe weight loss. If you’re trying to slim down, follow medical advice, avoid fake medicines and remember that healthy eating and regular exercise are still the safest ways to get in shape for summer.” 

Counterfeit Weight-Loss Pills Could Be the Next Online Health Scam

Pharmacist reveals the warning signs that a weight-loss medicine may be fake as the first GLP-1 tablet is approved in the UK

Consumers are being warned to watch for fake weight-loss tablets appearing on social media and unregulated websites following the approval of the first oral GLP-1 medicine for weight management in the UK.

The Medicines and Healthcare products Regulatory Agency approved the semaglutide tablet for weight loss on 11 June 2026, creating a needle-free alternative to injectable treatments.

However, Sobia Qasim, Superintendent Pharmacist at Curely, warns that growing public interest in weight-loss pills could also create a new opportunity for illegal sellers.

Unlike injectable pens, tablets can be placed in ordinary bottles, blister packs or envelopes and posted without specialist equipment, potentially making counterfeit products appear more convincing to consumers.

Fake medicines may contain the wrong dose, no active ingredient or entirely different and potentially harmful substances. The MHRA has already uncovered organised criminal networks manufacturing illegal weight-loss medicines and seized almost £45 million worth of illegal medicines during 2025.

Sobia said: “The arrival of an approved weight-loss tablet is an important development for patients, particularly those who are uncomfortable with injections. However, high demand and widespread online interest can also attract illegal sellers looking to exploit people who want quick or cheaper access.

“A tablet may look less suspicious than an injection because consumers are accustomed to receiving pills through the post. But a professional-looking box, blister pack or website does not prove that the medicine is genuine.

“Prescription weight-loss medication should only be supplied after an appropriate clinical assessment by a qualified healthcare professional. Any seller willing to bypass that process should immediately raise concern.”

Seven signs a weight-loss pill could be fake

Warning signWhy it should raise concern
It is sold through social media messagesGenuine prescription medicines should not be bought through private messages, marketplace listings or informal social media accounts.
No medical consultation is requiredWeight-loss medication is not suitable for everyone. A regulated provider should assess your health, current medicines and eligibility before prescribing it.
The seller guarantees a specific amount of weight lossResults differ between patients. Guaranteed outcomes are a marketing tactic, not responsible clinical advice.
You are pressured to act quicklyCountdown timers, limited stock claims and urgent payment requests may be used to stop consumers checking whether a provider is legitimate.
The price appears unusually lowA price substantially below recognised providers may indicate that the medicine is fake, unlicensed, incorrectly stored or obtained illegally.
The tablets arrive loose or in unfamiliar packagingMedicines should arrive in sealed, labelled packaging with clear dosage information and a patient information leaflet.
There is no registered pharmacy informationConsumers should be able to identify the pharmacy supplying the medicine and verify that it is registered with the appropriate UK regulator.

A familiar brand name does not guarantee a genuine product

Sobia warns that counterfeiters may copy recognised brand names, logos, batch numbers and packaging to make illegal products appear authentic.

In February 2026, the MHRA confirmed that a falsified version of a Mounjaro injection had been supplied through an online pharmacy in the UK. The regulator said fake medicines may contain incorrect ingredients, no active ingredient or harmful substances.

Previous fake GLP-1 injections discovered in the UK have also contained insulin, creating a risk of dangerously low blood sugar for people who unknowingly used them.

Sobia continued: “Counterfeiters can reproduce colours, logos and packaging extremely convincingly. Consumers should never judge a medicine by appearance alone.

The checks around the medicine are just as important as the product itself. Who prescribed it? Was a proper consultation completed? Which registered pharmacy supplied it? Can you contact a healthcare professional if something goes wrong?

If those questions cannot be answered clearly, do not take the tablets.

What consumers should check before ordering

Before purchasing weight-loss medication online, Curely recommends checking that:

  • Genuine clinical assessment is required
  • Qualified prescriber reviews the order
  • The dispensing pharmacy is registered in the UK
  • The provider asks about existing health conditions and medication
  • Clear contact details are available
  • The medicine arrives sealed and properly labelled
  • Instructions and patient safety information are included
  • Follow-up support is available throughout treatment

The NHS warns that medicines bought from unregistered websites may be out of date, diluted, fake or unsuitable for the person taking them.

What to do if you think a weight-loss medicine is fake

Anyone who believes they have received a counterfeit or suspicious medicine should not take another dose until they have spoken to a pharmacist or doctor.

Consumers should keep the packaging, receipt and details of the website or seller. Suspected fake medicines and side effects can be reported through the MHRA Yellow Card scheme.

Those who experience severe or persistent abdominal pain, repeated vomiting, difficulty breathing, loss of consciousness or symptoms of dangerously low blood sugar should seek urgent medical assistance.

Sobia added: “People may feel embarrassed if they have bought medication from an unofficial seller, but healthcare professionals need to know exactly what may have been taken so they can provide the right treatment.

Do not throw the packaging away and do not assume that feeling unwell is simply a normal side effect. With an unregulated product, there is no reliable way to know what the tablet contains or what dose has been supplied.

The safest route is always a properly regulated service offering clinical assessment, genuine medication and ongoing professional support.”

https://www.curely.co.uk/ 

Women on “skinny jabs” must use effective contraception, MHRA urges

Anyone who suspects that they’ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA. 

Women taking popular medicines for weight loss and diabetes, sometimes referred to as “skinny jabs”, are being reminded to use effective contraception while taking these medicines and, in some cases, for up to two months between stopping the medicine and trying to get pregnant.  

These medicines must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding. Anyone who gets pregnant while using them should speak to their healthcare professional and stop the medicine as soon as possible. This is because there is not enough safety data to know whether taking the medicine could cause harm to the baby. 

Effective contraception includes oral (the pill) and non-oral (the implant, coil or condoms) forms of contraception. However, Mounjaro may reduce the effectiveness of oral contraceptives in those who are overweight. Therefore, those taking Mounjaro who are overweight and are using an oral form of contraception are advised to also use a non-oral form of contraception. This only applies to those taking Mounjaro and is especially important for the four weeks after starting Mounjaro and after any dose increase. 
 
This advice, which is already in the patient leaflets that come with the medicine, is just one of the reminders in the latest guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) on the safe use of “GLP-1 medicines” known by the brand names Ozempic, Mounjaro, Wegovy, Saxenda and Victoza.  

The full advice can be found on the regulator’s website. It comes after concerns from the UK regulator that some people are not using these medicines for weight loss and diabetes safely.  

Dr Alison Cave, MHRA Chief Safety Officer said:Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments. They are not a quick fix to lose weight and have not been assessed to be safe when used in this way. 

“Our guidance offers patients a “one stop shop” for our up-to-date advice on how to use these powerful medicines safely.  

“This guidance should not be used as a substitute to reading the patient information leaflet or having a conversation with a healthcare professional as part of the prescribing process. ” 

Alongside advice on contraceptive use, the MHRA reminds patients that these medicines should not be bought from unregulated sellers such as beauty salons or via social media, or taken without a prior consultation with a healthcare professional.

Not only does this expose people wanting to lose weight to serious health risks, it is also against the law to sell these medicines in this way. 

The only way to guarantee receiving a genuine GLP-1 medicine is to obtain it from a legitimate pharmacy.  

The guidance also reminds patients of the symptoms to look out for in the event of acute pancreatitis which, although uncommon, can be serious.

The main symptom of this is severe pain in the stomach that radiates to the back and doesn’t go away. Anyone who experiences this should seek immediate medical help. 

Summary of advice to patients

  • You should only take GLP-1 medicines if they have been prescribed to you by a healthcare professional.   
  • Always have a conversation with your prescriber about the benefits and risks of GLP-1 medicines before you start taking them.   
  • Do not take GLP-1 medicines if you are pregnant, trying to get pregnant or breastfeeding. If you get pregnant while using them, you speak to a healthcare professional and stop them as soon as possible.
  • If you are prescribed Mounjaro (tirzepatide), use a barrier form of contraception and do not rely on oral contraception.   
  • Understand the potential side effects and have a conversation with a healthcare professional if you are concerned.   
  • Tell your doctor you take a GLP-1 medicine if you are about to have surgery.   
  • Report any adverse reactions to the Yellow Card scheme.   
  • After taking the recommended four doses in each syringe, any medicine left in the syringe should not be extracted and the syringe should be disposed of in the bin.  
  • Use of these medicines is not a quick fix to lose weight and the MHRA has not assessed the safety and effectiveness of these medicines when used by people who do not meet the medical requirements.   

Anyone who suspects that they’ve had an adverse reaction to a GLP-1 medicine,  or suspects it is not a genuine product, should report it to the MHRA Yellow Card scheme.